Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40)

Clinical trial NCT05204368 · UNKNOWN

Trial details

NCT number: NCT05204368
Sponsor: Evopoint Biosciences Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Complicated Urinary Tract Infection Including Acute Pyelonephritis

Start date: 2023-03-30
Primary completion: 2025-06-01
Enrollment: 780

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.